Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer Assay
Work
Year: 2010
Type: article
Abstract: The Oncotype DX® Colon Cancer Assay is a new diagnostic test for determining the likelihood of recurrence in stage II colon cancer patients after surgical resection using fixed paraffin embedded (FPE)... more
Source: BMC Cancer
Institutions Genomic Health (United States), Abbott (Sweden)
Cites: 52
Cited by: 92
Related to: 10
FWCI: 5.119
Citation percentile (by year/subfield): 94.94
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,195